At a glance
- Originator Nissan Chemical Industries
- Class Antiasthmatics; Antihypertensives; Oxadiazoles; Piperidines; Small molecules; Vasodilators
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Hypertension; Myocardial ischaemia
Most Recent Events
- 21 Feb 2000 Discontinued-Preclinical for Myocardial ischaemia in Japan (Unknown route)
- 21 Feb 2000 Suspended-Preclinical for Asthma in Japan (Unknown route)
- 21 Feb 2000 Suspended-Preclinical for Hypertension in Japan (Unknown route)